(2) Immunology : Innate & Acquired Immunity . 2008 .

. ..

( ! ; )
V ־_
Innate (Nonspecific) Immunity
:
: $ % & #
.. : Mechanical Factors )* .(
. •
. ! "# $ •
.& % •
. ' ( &! •
: Chemical Factors $ # , & - )* .+
.+ , " #- • . * ) "# $ •
. # # • .. / !01 •
.' • . 2 . " #- •
. "4 5 1 PH • . 1 3 "# $ •
:% % * / ..
. ! / ;4 2 5 < ;! = ( ! 6 ) ! 6 # 7 * 81 •
." , 6A 6 $ 1 ?/ @ > 1? ( <; •

- -
 (2) Immunology : Innate & Acquired Immunity . 2008 .

: % % & #
: )2 * , ! (
: : - 0 .(
. ! . :0 ) ) .a
?=C ( 3 D? ;5 C1 B C3 3 : .b
3 ?2 ;5 ( 5 C?) C4 = C2 = C1 E !
.
= " $ ) F <; " $ > *> + : & 1 .c
G . 5 7 , B G @ 27 " $ D
. I 2 1 J ( D & C; C ! + 5 HF
: *' ?. D •
. ! : Inf -
.E F K % " # $ : Inf -
.( G 2 ) F # $ : Inf -

: # .+
: 27 ( : !# .a
. "G * (LE . ) : Microphagocytes . 4, " •
! M;* . 4, *? !? 5 (. . 1 ) : Macrophagocytes . ! " •
. ! $ ! F 6 N 6 ? ! ?
V Dynamics of phagocytosis<íÛÃ×fÖ]<Øu]†Ú
Øu]†Ú
. C5a C3a 6A "1 < ; : Chemotaxis %- /2* (L
: <; > + *? : 3 4 (O
. 4 -

. C3b > , , -

. Phagosome . $ ! : 5! 4 (P
: D : # $# 6 7 $8 (Q
!? " ! ! Oxidative Mechanisms ! 2 ( -
. H2 O2 6
: Non-Oxidative Mechanisms ! 2 ( -
.E " # !F " # #

Polymorphonuclear leukocytes (PMNs) >> Neutrophils (most aggressive) + Eosinophils (antiparasitic) + Basophils 1

- -
 (2) Immunology : Innate & Acquired Immunity . 2008 .

: (Natural Killer Cells) NK 8 !# .b

. 51 2 " 27 ($ . ! " $ . * •
1 ( ! ?" $ ) F " $ 6 F )B •
. 3 " 1 .

V íב`j¹]<íÂ^ß¹]<»<†möi< Ö]<ØÚ]çÃÖ]
. - ( +, ; &$ $ ! : Species : * $ 9(
.0 6!? ,R >F6 H # 5 : Races 3 9+
5A # ( $ 2 ) G6PD # # , 2 : 0 &! #4 9.
. F (
. ) ! ) , " ,- * 6!? B : Age 9;
. ! ! 1 ! T( 2 7 C S ;4 T( : - 2= 9<
,R +*S ( 5 ? A " !? >/ ) ( " : 0 7 9>
.( T( ) C ! 2 < ;! -
. $ 9?

V^ íe^rj‰÷]<î×Â<ì†mö¹]<ØÚ]çÃÖ]æ<l]‚–jŠ¹]<“ñ^’}
: 8 $ .A
Self # B 81 > ! ?+ : = .(
D, , 4 ! 5 U C ( / 4 :>F6 Nonself 4
. (Goodpaster Syndrome #F ) D ? ! > M
)? D ) ! >@@@ !? # # ! ?+ : %- )* ) .+
. G 0 1 B G > G <;
A =" ' ? ? > .# " ; " : / ..
. ! " *
:3 3 .;
. 3 (1 ( ) ! ! ! ?+ : .a
! 0 1 G * : (Adjuvants ) . .b
. G # 5@ " B
: Host A 8 $ .B
." F 5 ) $ 1 '

- >-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

V l]‚–jŠ¹]<½^´_
: * : .a
. V . Soluble 1 V
.( )O" V .( *) H " V
. (E.coliW 1 )K" V . Vi " V
: & : .b
0 1 B 5 "1( 1 >. * )& $ %F4 " •
.( + CA ( ? !
. %! # $ ! 1 " •
: 20 .c
. # " •
.O HLA 3 " •

V Cross Reaction gÖ^’j¹]<ØÂ^ËjÖ]

. 6 0 " 5 " B $ * •
. 1 " D +( " ,B 1( 1 ?+ , 5 6 •
( ( " 1 5 ) : . " , M;* * •
. & $ N : Paul- Bunnel $ -
. (& $ ,- % ! 8 1) # $ -
. (" ! & $ 2 1T ) Weil- Felix $ -
. #F ! N : Cold Agglutinins . ", $ -

V Antigens or Immunogens l^ÃßÛjŠ¹]<æ_<l]‚–jŠ¹]

! 81 ! Immunogenicity + 0 1 2 . ) *' G •
. ) $ .
.+ > !1 5 B => ; ?> > ! ) •

V<Hapten °je^ ]
. 0$ # D# 0 1 M1 B G+ * •
. G 8 17 2 > )X, D 1 ! 1 27 H 1 5 •
.( W" 5 W" $ W ) 6 0 5 6 ? *? •

" ! ! 2 ? ( 3 ! ! = 6 ( = / ' # * * : Human Leucocyte Antigen 2

. ?N

- E-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

V<Epitopes h^fÏÖ]<æ_<íè‚–jŠ¹]<l]4‚5]
. Monoclonal . 1 ? ! 2 0 1 /# * •
. ? 0 1 (ZVQ) %A C 1 ! •
. $ Ab ' ? [ 0 1 D ? C? " 1 [< >F6 C •

V ^éÂ^ßÚ<]…æ4 gÃ×i<ï†}_<^èø}
. Eosinophils " 1 9(
. Basophils " 9+
. Neutrophils "G 9.
. ( ,,$ . )E " 5

: Eosinophils
. (>F6 ) 1 0 5 •
0 ! 2 ! )" $ 1 > + $ " G 0 ? . 6! •
. (N 5! X, ? ) C?
. WBC / " ! %<9+ ! •
* (Degranulation + 1 () " 1 5 1 J 5@ F . 6 5 8 1 ;7 •
.. 5 B G " 51F
. F( < •
+; 5 *? F 5( 3 +5 G ! 27 " 1 +; •
. (Eosinophil Chemotactic Factor of Anaphylaxis) ECFA )\ " 1
"F $ 0 + 8 17 > " 1 5( " 0 + •
M;* + ! ( ,( . 5K F + , C; + !) 1
. $ ") 2 / ( > *> "

: Neutrophils
.( 5 * 2 ;* ) E " ' %C@ ! •
1 " Phagosomes 2 " ! 5 •
. Phagolysosome 1 " 2 ! Lysosome
. F > > 6A 5!F G - F! 5 •
." /[/ * %, •
.( $ , ) Chemotactic ; 6A +; •

3
Neutrophils function in the innate BUT NOT IN AQUIRED immunity

- L-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

: Basophils
E ?" ! 5 5 6 Vasoactive > 2 C 1 •
+, IgE 4 Fc . ( "F ( 51 2 = +5 G
. F 5 # > 1?

: Mast Cells
. "1 F •
. J 5) 4 # B •
( "F ( 5 5 " D •
. IgE 4 Fc .
+ 1 ' & 1 S •
. (3\ % ?) & ! (
5 5 5 *? . 6! C 1 •
. * )\ " 1 +;
. 6A "1 5 J •
5 ( •
+1 ( 5 1 J 2 7 C S >1 )
. Degranulation
." $ 5 •

: platelets
.C ( ,? /# ? •
. 6 5 •
.( D 1 ) 5 G $ / !;@ ( •

- M-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

( ) * 4 V ^éÞ^m
Acquired4 Immunity Response
: ) 27 (
Humoral ) B.cells F " 4 H @ G 9(
. (Immunity
. (Cellular Immunity ) T.cells F G 9+
= K ( = 1 = $ ( ) ! #5 #4 - F : >;7 •
. (T , B) 5 = $ 5 (1 (&

V B Lymphocyte<íéñ^fÖ]<íèæ^ËÛ×Ö]<^èø¤]
! - D ( & + ; F F M;* A •
.B F (Pre- B Cell) B $ F 81= K ( ?
. " Plasma cells B.cells PB : !;
! IgM 4 51 2 B F 1^ •
" "F ( ! = _ IgD W < ;! B
. , "F ( > ?< !
ZV_ * = " $ %30 F ! •
.T F ,)? * ?
F 27 # " 6A "1 B F •
+ 6 $ / ;* ,1 #F
." (TH) . T F ! M;*
:3 F # •
. IgM W ? 3A 5 .a
[
EAC 1 " ! .b
. . 1

It’s called Adaptive Immunity too 4

. I 21 ! D$K % IgD 5
. Erythrocyte Antibody Complement = EAC 6

- N-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

V T Lymphocyte<íéñ^jÖ]<íèæ^ËÛ×Ö]<^èø¤]
.< *# 27 5 6 K ( Stem Cell ; F A •
." . 27 5 ? . J * = " $ %D@9>< F ! •
CD # ) 2 ! " # $S " 51 2 •
. . 1 ?B $ * = ...CD8-CD4-CD3 6 (Cluster Differentiation)
: 2 7 M;* # ) + 1 F ( <; 2 >/ •

: TH # $ % & ' !( CD4 ! " .

. "# & + #4 T F 7 %>< ! -
. MHC-II 3 "F ( # B -
.Z APC " ( F X 2
. (>F6 # - & )" $ ) a 5` F * -
. G K 2 ! S -
. TH2 TH1 2 7 " ! $ 5)F 7 + 1 TH ( -
. ! " 0 1 " ! $ # $ : TH1 .a
G 2 T F ' ? 0
& 1 $ 1 M;* 2 3
.8 DTH I
) H 72 F 0 1 : TH2 .b
. (IgM

: TH % K -
F D ( 1 - < ; ) IgM H 72 #F F (a
. (THW 1 IgMW D 7+ " G.
. ( TC 0 1 ( (b
.( 5 # TS TH 8 1) 6 Ts 0 1 ( (c
F > 1 > 6A < " ! $ 6 $ 1 1 (d
." NK ( F F 6

. Antigen-Presenting Cell = APC 7

Delayed Type Hypersensitivity = DTH 8

- S-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

: CD8 ! " .
.T F 7 %.< ! -
. (Ts) 6 T F (Tc) ( T F * "1 -
F & $ F 1 = MHC-I 3 # : 8 .a
.. F
. G K > *> + T F B F 6 : .b

V DNullcellsE T ÷æ B<kŠéÖ<^èø}
(NK ( ) ( F M;* = $ F %(@9< ! -
. Monocytes . 1 F 0 B T" $ . ! 1 27 -

: 0E !
. (% 5 ) %L ! CD4 CD8 " >F! C 1 T F < * .(
. (TH < 6 < Ts < 0 1 < TH) B ( \ TH B Ts $ .+
: APC ( F *? ..
. MAC . ! " (a
. Dendritic ,4 F (b
. F (c
" ! $ 1 F ? . 7 F ) B . F .;
. (" ! )

V T memory cell<ì†Ò]„Ö] T<^èø}

B 5@ 6 . ;* 1 = 0 F 5K # -
. B : D A %, ! 5 ( M#

V Natural Killer Cell<íéÃéfAÖ]<í×i^ÏÖ]<^èø¤]

.B T F 1 " + ? 5,( 1 . ! $ F * -
5 >. <;) & $ F F 2 ) < -
. ("G 1 M;* < 1
.O ! - - 5 # -
) $d4 F 1 2 . ( 5 FC "F ( F M;* < -
. (ADCC ? Antibody Depent Cellular Cytoxic

- V-
 (2) Immunology : Innate & Acquired Immunity . 2008 .

: K1F
LAC ( F $ ! $ 2 ( F $ C; (IL2) ! G
%5 F )2 ! ! . ) F M;* (Lymphokine Activated Killer Cell)
( .# N D ;* = LAC F , F 6 NK ) 1
. "
- LAK cell : is a white blood cell that has been stimulated to kill tumour cells . If lymphocytes are cultured in the
presence of Interleukin 2, it results in the development of effector cells which are cytotoxic to tumour cells.
- LAK cell : A white blood cell that is stimulated in a laboratory to kill tumor cells . www. wikipedia.org

V Macrophages<l^ÃÖ^fÖ]
. K ( Premonocytes . 1 $ 3 •
Premonocytes Monocytes Macrophages
. ! $ ! F 6 / 0 6 ? E . 1 ! ? 7 * •
B) 2 7 +; g f$^ 1 81 ! ; " e * X F ! •
6 $ , 1 ?( X ) $ " !
. C5, C3
: 5$ K •
. .L
" T < ; ## FC B $ FC W 1 "F ( < .O
.( 5 ) $4
. APC " ( F ! .P
.T F 6! $ C; (IL1) 1 ! G N .Q
. (ADCC) F F $4 F 1 ._
. , B, F # $ .[

V ífŠjÓ¹]<íÂ^ß¹]<Å]çÞ_
. Passive $ ! Active ! 27 ! (

: Active Immunity 9I
: 27 ( =/ ? ? 0 81
"1 ?C N 81 : Natural Active Immunity & .a
.. 1 E ! 81 %! ,1 ,- : >F6 = C
1 "1( / 7 81 : Artificial Active Immunity & .b
. (" $ ; ) 5 ? ( ? $

- >W -
 (2) Immunology : Innate & Acquired Immunity . 2008 .

l^u^Ï×Ö]<Å]çÞ_ *
V<l^u^Ï×Ö]<Å]çÞ_
. $ < J( $ . K $ 2 1 J( 6 : 8 0 8 •
/ $, 2 1 D-17 J ( $ J( B.C.G J ( 6 : 0 8 •
. # #! 6 6 0 " $; T(@ 1 : Toxoids 0 2 •
" ! %S ) 1 +5 J( 6 : * G )*: 0 8 •
.( 1 " ! K$1 .
.( ! + 5 ) HBV J ( 6 DNA W + A ( <; : HI 0 8 •

: Passive Immunity 9II

: 5 #* ! 2 *
IgGW ( 81 : Natural Passive Immunity .a
= + 13 B 2 7 IgAW ( ? 27 .#*
..G 2 5 ?[ F . 0 ? 1 >G S ' ;*
: ) ? M;* : Artificial Passive Immunity .b
. $; , (1 -
"G 1 B & 1 * ; T 1 X W (1 -
. HBV ! + 5 ? $ ? ,1

-> -
(2) Immunology : Innate & Acquired Immunity . 2008 .

J# 3

6 * %& 5 & 3 9(

6 0 $H 9+

-> -
(2) Immunology : Innate & Acquired Immunity . 2008 .

B-cells T-cells $ $ H 9.

- >> -
 (2) Immunology : Innate & Acquired Immunity . 2008 .

6 %& K # (()

! ' ... $ F ! 9( G F F E 17 9@
: " $ :
. % hiV[_ .A . B lymphocyte .A
. % Q_ .B . CD4+T-helper 1lymphocyte .B
. % _[ .C . CD4+T-helper 2 lymphocyte .C
. % Q_VPO .D . Macrophage .D
0 1 2 1 ... # # ! ? + 9. : ! F C? 9+
: . Neutrophil .A
. Piii !? .A . Macrophage .B
. [iii !? .B . B cell .C
jiii !? .C . Langerhans cell in the skin .D
. ? _ "; 0 26 ? # !? .D
:& 1 ' ... 9< : . ! ; 9;
. IgD + IgM .A . T cells and B cells .A
. NK cells .B . Macrophages and B cells .B
. IgE .C . B cells and dendritic cells .C
. IgA .D . T cells and NK cells .D
:& 1 6 ' ... 9? B F X 2 H # C? 9>
. IgE .A :
. IgM + IgG .B . IgE and IgA .A
. IgA + IgM .C . IgG and IgD .B
. None .D . IgM and IgE .C
. IgM and IgD .D
: %A C 1 ! 9C & 1 2 6! J( ? ! 9D
. ? 0 1 ZiVQi .A :'
. ? 0 1? C 1 G .B . Stimulating & .A
. ? 0 1 LZVLQ .C . Immune complex 8 6 .B
. ? 0 1 ZVQ .D . Delayed 6 .C
. None .D

2 D 6 . 1 5
) : % 7

- >E -